These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 21450126)
1. Health technology assessment in the era of personalized health care. Becla L; Lunshof JE; Gurwitz D; Schulte In den Bäumen T; Westerhoff HV; Lange BM; Brand A Int J Technol Assess Health Care; 2011 Apr; 27(2):118-26. PubMed ID: 21450126 [TBL] [Abstract][Full Text] [Related]
2. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research. Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G; Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133 [TBL] [Abstract][Full Text] [Related]
3. Health technology assessment: research trends and future priorities in Europe. Nielsen CP; Funch TM; Kristensen FB J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525 [TBL] [Abstract][Full Text] [Related]
4. Development of health technology assessment in China: New challenges. Chen Y; He Y; Chi X; Wei Y; Shi L Biosci Trends; 2018; 12(2):102-108. PubMed ID: 29760354 [TBL] [Abstract][Full Text] [Related]
5. The Future of Precision Medicine: Potential Impacts for Health Technology Assessment. Love-Koh J; Peel A; Rejon-Parrilla JC; Ennis K; Lovett R; Manca A; Chalkidou A; Wood H; Taylor M Pharmacoeconomics; 2018 Dec; 36(12):1439-1451. PubMed ID: 30003435 [TBL] [Abstract][Full Text] [Related]
6. Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA. Kristensen FB; Lampe K; Chase DL; Lee-Robin SH; Wild C; Moharra M; Garrido MV; Nielsen CP; Røttingen JA; Neikter SA; Bistrup ML; Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():1-8. PubMed ID: 20030885 [TBL] [Abstract][Full Text] [Related]
7. Health technology assessment of medical devices: What is different? An overview of three European projects. Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131 [TBL] [Abstract][Full Text] [Related]
8. The development of health technology assessment. Banta D Health Policy; 2003 Feb; 63(2):121-32. PubMed ID: 12543525 [TBL] [Abstract][Full Text] [Related]
9. Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling. Tarride JE; Gould T; Thomas DM Int J Technol Assess Health Care; 2022 Jun; 38(1):e57. PubMed ID: 35674123 [TBL] [Abstract][Full Text] [Related]
10. The contribution of health technology assessment, health needs assessment, and health impact assessment to the assessment and translation of technologies in the field of public health genomics. Rosenkötter N; Vondeling H; Blancquaert I; Mekel OC; Kristensen FB; Brand A Public Health Genomics; 2011; 14(1):43-52. PubMed ID: 20926845 [TBL] [Abstract][Full Text] [Related]
11. Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies. Trosman JR; Weldon CB; Douglas MP; Deverka PA; Watkins JB; Phillips KA Value Health; 2017 Jan; 20(1):40-46. PubMed ID: 28212967 [TBL] [Abstract][Full Text] [Related]
12. Health technology assessment: a sociological commentary on reflexive innovation. Webster A Int J Technol Assess Health Care; 2004; 20(1):61-6. PubMed ID: 15176178 [TBL] [Abstract][Full Text] [Related]
13. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges. Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531 [TBL] [Abstract][Full Text] [Related]
14. Genetics and genomics: the scientific drivers of personalized medicine. Kurnat-Thoma EL Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497 [TBL] [Abstract][Full Text] [Related]
15. Role of health technology assessment in shaping the benefits package in The Netherlands. Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181 [TBL] [Abstract][Full Text] [Related]
16. New trends and challenges in the European regulation of innovative medicines. Enzmann H Regul Toxicol Pharmacol; 2016 Oct; 80():314-20. PubMed ID: 27237379 [TBL] [Abstract][Full Text] [Related]
17. Personalized cancer medicine and the future of pathology. Moch H; Blank PR; Dietel M; Elmberger G; Kerr KM; Palacios J; Penault-Llorca F; Rossi G; Szucs TD Virchows Arch; 2012 Jan; 460(1):3-8. PubMed ID: 22143935 [TBL] [Abstract][Full Text] [Related]
18. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation. Guthrie S; Bienkowska-Gibbs T; Manville C; Pollitt A; Kirtley A; Wooding S Health Technol Assess; 2015 Aug; 19(67):1-291. PubMed ID: 26307643 [TBL] [Abstract][Full Text] [Related]
19. [Policy developments of health technology assessment in the European Union]. Baran-Kooiker A; Czech M; Hołownia-Voloskova M Postepy Biochem; 2019 Nov; 65(4):319-321. PubMed ID: 31945287 [TBL] [Abstract][Full Text] [Related]
20. Reflections on the evolution of health technology assessment in Europe. Sorenson C; Chalkidou K Health Econ Policy Law; 2012 Jan; 7(1):25-45. PubMed ID: 22221927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]